Systemic angiopoietin-1/2 dysregulation following cardiopulmonary bypass in adults
Author(s) -
Emmanuel Charbonney,
Elizabeth Wilcox,
Yuexin Shan,
Pablo Pérez d’Empaire,
Abhijit Duggal,
Gordon D. Rubenfeld,
Conrad Liles,
Claúdia C. dos Santos
Publication year - 2017
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.4155/fsoa-2016-0072
Subject(s) - cardiopulmonary bypass , medicine , angiopoietin 2 , angiopoietin , endothelial dysfunction , observational study , cardiology , positive correlation , vascular endothelial growth factor , vegf receptors
Aim: Vascular leakage following cardiopulmonary bypass contributes to morbidity. Angiopoietin-1 and -2 are biomarkers of endothelial dysfunction. Our aim was to characterize Ang-1 and -2 association with clinical characteristics and outcomes. Methods: Observational cohort study measuring Ang-1/-2 with a panel of cytokines in adults undergoing cardiopulmonary bypass. Results: Ang-2 levels increased immediately postop whereas Ang-1 levels decreased over time. No significant correlation was found with other inflammatory mediators. High correlation was found between the hospital length of stay and Ang-2 increase at 24 h (rho = 0.590; p < 0.0001). The predictors of Ang-2 increase were female gender, cross clamp time, transfusion of blood and absence of angiotensin-converting enzyme inhibitor as a pre-op medication. Conclusion: Angiopoietins can detect vascular leakage early and could impact patient's management to decrease length of stay after cardiac surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom